Buyer Name: NHS Shared Business Services Limited
Buyer Address: Three Cherry Trees Lane, Hemel Hempstead, UKH23, HP2 7AH, United Kingdom
Contact Email: nsbs.categorymanagementsourcing@nhs.net
Buyer Name: NHS Shared Business Services Limited
Buyer Address: Three Cherry Trees Lane, Hemel Hempstead, UKH23, HP2 7AH, United Kingdom
Contact Email: nsbs.categorymanagementsourcing@nhs.net
NHS Shared Business Services act in an Agency capacity for and on behalf of its customers (Approved Organisations) - existing and new. These comprise of NHS and Social Care organisations (whether acting individually, or on behalf of, or together as members of any consortia) along with any other public or private sector bodies which NHS SBS authorises to use the resulting Framework. NHS Shared Business Services Limited (NHS SBS) intends to put in place a Framework Agreement for the provision of Radiopharmaceutical Products to be used by NHS SBS Approved Organisations. Our Approved Organisation list can be found on: https://www.sbs.nhs.uk/services/framework-agreements-categories/ The Framework will be structured using the following Lots; Lot 1 - Diagnostic and Therapeutic Radiopharmaceutical Products Lot 2a - Technetium and Krypton Generators Lot 2b - Gallium Generators We are committed to working with suppliers who are dedicated to Sustainability and Social Value and there will be a significant weighting on these elements in the tender.
No linked documents found for this notice.
External Link: https://www.find-tender.service.gov.uk/Notice/011276-2025
Link Description: Tender notice on Find a Tender
Lot Title: Diagnostic and Therapeutic Radiopharmaceutical Products
Lot Description: This Lot is for the provision of ready to use Radiopharmaceuticals and kits for Radiopharmaceutical preparation. Bidders must deliver all mandatory requirements as detailed in the Specification section of the Framework Agreement There are additional Selection Qualification (SQ), Award Questionnaire (AQ) requirements, and Bidder Declarations applicable, and Bidders are asked to respond to these also. Where the Bidder does not score a minimum of 55% in total (AQ and total commercial score combined) the Authority shall exclude the submission from being appointed to the framework.
Lot 1 Status: active
Lot 1 Value: GBP 150,000,000
Lot 1 Value (Gross): GBP 180,000,000
Lot 1 Contract Start: 2026-01-05T00:00:00Z
Lot 1 Contract End: 2029-01-04T23:59:59Z
Lot 1 SME Suitable: Yes
Lot 1 Award Criterion (quality): AQ (70%)
Lot 1 Award Criterion (quality): Social Value (10%)
Lot 1 Award Criterion (price): Commercial (20%)
Lot Title: Technetium and Krypton Generators
Lot Description: This Lot is for the provision of Technetium and Krypton Generators. These radionuclide generators are devices which provide a local supply of a short-lived radioactive substance from the decay of a longer-lived parent radionuclide. Found commonly in a nuclear medicine department, they are used for a variety of nuclear medicine diagnostic procedures. Bidders must deliver all mandatory requirements as detailed in the Specification section of the Framework Agreement. There are additional Selection Qualification (SQ), Award Questionnaire (AQ) requirements, and Bidder Declarations applicable, and Bidders are asked to respond to these also. Where the Bidder does not score a minimum of 55% in total (AQ and total commercial score combined) the Authority shall exclude the submission from being appointed to the framework.
Lot 2a Status: active
Lot 2a Value: GBP 150,000,000
Lot 2a Value (Gross): GBP 180,000,000
Lot 2a Contract Start: 2026-01-05T00:00:00Z
Lot 2a Contract End: 2029-01-04T23:59:59Z
Lot 2a SME Suitable: Yes
Lot 2a Award Criterion (quality): AQ (70%)
Lot 2a Award Criterion (quality): Social Value (10%)
Lot 2a Award Criterion (price): Commercial (20%)
Lot Title: Gallium Generators
Lot Description: This Lot is for the provision of Gallium Generators. These radionuclide generators are devices which provide a local supply of a short-lived radioactive substance from the decay of a longer-lived parent radionuclide. Found commonly in a nuclear medicine department, they are used for a variety of nuclear medicine diagnostic procedures. Bidders must deliver all mandatory requirements as detailed in the Specification section of the Framework Agreement. There are additional Selection Qualification (SQ), Award Questionnaire (AQ) requirements, and Bidder Declarations applicable, and Bidders are asked to respond to these also. Where the Bidder does not score a minimum of 55% in total (AQ and total commercial score combined) the Authority shall exclude the submission from being appointed to the framework.
Lot 2b Status: active
Lot 2b Value: GBP 150,000,000
Lot 2b Value (Gross): GBP 180,000,000
Lot 2b Contract Start: 2026-01-05T00:00:00Z
Lot 2b Contract End: 2029-01-04T23:59:59Z
Lot 2b SME Suitable: Yes
Lot 2b Award Criterion (quality): AQ (70%)
Lot 2b Award Criterion (quality): Social Value (10%)
Lot 2b Award Criterion (price): Commercial (20%)
Document Description: Not published
Document Description: Tender notice on Find a Tender
{
"buyer": {
"id": "GB-COH-05280446",
"name": "NHS Shared Business Services Limited"
},
"date": "2025-03-26T10:44:35Z",
"id": "011276-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-04f8cf",
"parties": [
{
"additionalIdentifiers": [
{
"id": "PDVT-6171-VHCX",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Hemel Hempstead",
"postalCode": "HP2 7AH",
"region": "UKH23",
"streetAddress": "Three Cherry Trees Lane"
},
"contactPoint": {
"email": "nsbs.categorymanagementsourcing@nhs.net"
},
"details": {
"classifications": [
{
"description": "Public undertaking",
"id": "publicUndertaking",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.sbs.nhs.uk/"
},
"id": "GB-COH-05280446",
"identifier": {
"id": "05280446",
"scheme": "GB-COH"
},
"name": "NHS Shared Business Services Limited",
"roles": [
"buyer"
]
}
],
"tag": [
"tender"
],
"tender": {
"aboveThreshold": true,
"awardPeriod": {
"endDate": "2025-11-03T23:59:59Z"
},
"coveredBy": [
"GPA",
"CPTPP"
],
"description": "NHS Shared Business Services act in an Agency capacity for and on behalf of its customers (Approved Organisations) - existing and new. These comprise of NHS and Social Care organisations (whether acting individually, or on behalf of, or together as members of any consortia) along with any other public or private sector bodies which NHS SBS authorises to use the resulting Framework.\nNHS Shared Business Services Limited (NHS SBS) intends to put in place a Framework Agreement for the provision of Radiopharmaceutical Products to be used by NHS SBS Approved Organisations.\nOur Approved Organisation list can be found on: https://www.sbs.nhs.uk/services/framework-agreements-categories/\nThe Framework will be structured using the following Lots;\nLot 1 - Diagnostic and Therapeutic Radiopharmaceutical Products\nLot 2a - Technetium and Krypton Generators\nLot 2b - Gallium Generators\nWe are committed to working with suppliers who are dedicated to Sustainability and Social Value and there will be a significant weighting on these elements in the tender.",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
},
{
"datePublished": "2025-03-26T10:44:35Z",
"description": "Tender notice on Find a Tender",
"documentType": "tenderNotice",
"format": "text/html",
"id": "011276-2025",
"noticeType": "UK4",
"url": "https://www.find-tender.service.gov.uk/Notice/011276-2025"
}
],
"enquiryPeriod": {
"endDate": "2025-04-11T12:00:00+01:00"
},
"id": "SBS10516",
"items": [
{
"additionalClassifications": [
{
"description": "Radioactive materials",
"id": "09343000",
"scheme": "CPV"
},
{
"description": "Medical equipments, pharmaceuticals and personal care products",
"id": "33000000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UK"
},
{
"country": "GG",
"countryName": "Guernsey",
"region": "GG"
},
{
"country": "IM",
"countryName": "Isle of Man",
"region": "IM"
},
{
"country": "JE",
"countryName": "Jersey",
"region": "JE"
}
],
"id": "1",
"relatedLot": "1"
},
{
"additionalClassifications": [
{
"description": "Radioactive materials",
"id": "09343000",
"scheme": "CPV"
},
{
"description": "Medical equipments, pharmaceuticals and personal care products",
"id": "33000000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UK"
},
{
"country": "GG",
"countryName": "Guernsey",
"region": "GG"
},
{
"country": "IM",
"countryName": "Isle of Man",
"region": "IM"
},
{
"country": "JE",
"countryName": "Jersey",
"region": "JE"
}
],
"id": "2a",
"relatedLot": "2a"
},
{
"additionalClassifications": [
{
"description": "Radioactive materials",
"id": "09343000",
"scheme": "CPV"
},
{
"description": "Medical equipments, pharmaceuticals and personal care products",
"id": "33000000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UK"
},
{
"country": "GG",
"countryName": "Guernsey",
"region": "GG"
},
{
"country": "IM",
"countryName": "Isle of Man",
"region": "IM"
},
{
"country": "JE",
"countryName": "Jersey",
"region": "JE"
}
],
"id": "2b",
"relatedLot": "2b"
}
],
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"name": "AQ",
"numbers": [
{
"number": 70,
"weight": "percentageExact"
}
],
"type": "quality"
},
{
"name": "Social Value",
"numbers": [
{
"number": 10,
"weight": "percentageExact"
}
],
"type": "quality"
},
{
"name": "Commercial",
"numbers": [
{
"number": 20,
"weight": "percentageExact"
}
],
"type": "price"
}
]
},
"contractPeriod": {
"endDate": "2029-01-04T23:59:59Z",
"startDate": "2026-01-05T00:00:00Z"
},
"description": "This Lot is for the provision of ready to use Radiopharmaceuticals and kits for Radiopharmaceutical preparation.\nBidders must deliver all mandatory requirements as detailed in the Specification section of the Framework Agreement \nThere are additional Selection Qualification (SQ), Award Questionnaire (AQ) requirements, and Bidder Declarations applicable, and Bidders are asked to respond to these also. \nWhere the Bidder does not score a minimum of 55% in total (AQ and total commercial score combined) the Authority shall exclude the submission from being appointed to the framework.",
"id": "1",
"selectionCriteria": {
"criteria": [
{
"description": "Please see the procurement documentation.",
"type": "economic"
},
{
"description": "Please see the procurement documentation.",
"type": "technical"
}
]
},
"status": "active",
"suitability": {
"sme": true
},
"title": "Diagnostic and Therapeutic Radiopharmaceutical Products",
"value": {
"amount": 150000000,
"amountGross": 180000000,
"currency": "GBP"
}
},
{
"awardCriteria": {
"criteria": [
{
"name": "AQ",
"numbers": [
{
"number": 70,
"weight": "percentageExact"
}
],
"type": "quality"
},
{
"name": "Social Value",
"numbers": [
{
"number": 10,
"weight": "percentageExact"
}
],
"type": "quality"
},
{
"name": "Commercial",
"numbers": [
{
"number": 20,
"weight": "percentageExact"
}
],
"type": "price"
}
]
},
"contractPeriod": {
"endDate": "2029-01-04T23:59:59Z",
"startDate": "2026-01-05T00:00:00Z"
},
"description": "This Lot is for the provision of Technetium and Krypton Generators.\nThese radionuclide generators are devices which provide a local supply of a short-lived radioactive substance from the decay of a longer-lived parent radionuclide. Found commonly in a nuclear medicine department, they are used for a variety of nuclear medicine diagnostic procedures.\nBidders must deliver all mandatory requirements as detailed in the Specification section of the Framework Agreement.\nThere are additional Selection Qualification (SQ), Award Questionnaire (AQ) requirements, and Bidder Declarations applicable, and Bidders are asked to respond to these also. \nWhere the Bidder does not score a minimum of 55% in total (AQ and total commercial score combined) the Authority shall exclude the submission from being appointed to the framework.",
"id": "2a",
"selectionCriteria": {
"criteria": [
{
"description": "Please see the procurement documentation.",
"type": "economic"
},
{
"description": "Please see the procurement documentation.",
"type": "technical"
}
]
},
"status": "active",
"suitability": {
"sme": true
},
"title": "Technetium and Krypton Generators",
"value": {
"amount": 150000000,
"amountGross": 180000000,
"currency": "GBP"
}
},
{
"awardCriteria": {
"criteria": [
{
"name": "AQ",
"numbers": [
{
"number": 70,
"weight": "percentageExact"
}
],
"type": "quality"
},
{
"name": "Social Value",
"numbers": [
{
"number": 10,
"weight": "percentageExact"
}
],
"type": "quality"
},
{
"name": "Commercial",
"numbers": [
{
"number": 20,
"weight": "percentageExact"
}
],
"type": "price"
}
]
},
"contractPeriod": {
"endDate": "2029-01-04T23:59:59Z",
"startDate": "2026-01-05T00:00:00Z"
},
"description": "This Lot is for the provision of Gallium Generators. \nThese radionuclide generators are devices which provide a local supply of a short-lived radioactive substance from the decay of a longer-lived parent radionuclide. Found commonly in a nuclear medicine department, they are used for a variety of nuclear medicine diagnostic procedures.\nBidders must deliver all mandatory requirements as detailed in the Specification section of the Framework Agreement.\nThere are additional Selection Qualification (SQ), Award Questionnaire (AQ) requirements, and Bidder Declarations applicable, and Bidders are asked to respond to these also. \nWhere the Bidder does not score a minimum of 55% in total (AQ and total commercial score combined) the Authority shall exclude the submission from being appointed to the framework.",
"id": "2b",
"selectionCriteria": {
"criteria": [
{
"description": "Please see the procurement documentation.",
"type": "economic"
},
{
"description": "Please see the procurement documentation.",
"type": "technical"
}
]
},
"status": "active",
"suitability": {
"sme": true
},
"title": "Gallium Generators",
"value": {
"amount": 150000000,
"amountGross": 180000000,
"currency": "GBP"
}
}
],
"mainProcurementCategory": "goods",
"participationFees": [
{
"description": "We apply an NCIS (NHS Contracted Income Stream) levy to all sales under our Frameworks, which underpins the funding and investment for our contracting routes and category support to the NHS. This levy is applied as a percentage fee within the Frameworks between the Authority and the Supplier. \nPlease see the Corporate Requirements document within the Key Attachments section of the SAP Ariba Souring Event for further details.",
"id": "ocds-h6vhtk-04f8cf",
"relativeValue": {
"monetaryValue": "award",
"proportion": 0.01
},
"type": [
"win"
]
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "active",
"submissionMethodDetails": "Tenders must be submitted via SAP Ariba via the following link: \nhttps://discovery.ariba.com/rfx/22823093\nTo access all information and submit a response in relation to this opportunity, please click the \u0027Respond to Posting\u0027 button on the Discovery Posting link above. Potential bidders will then be asked to either login or register for an Ariba Network account. Once registration has been completed, potential bidders will be directed to the Event Page.",
"submissionTerms": {
"electronicSubmissionPolicy": "allowed",
"languages": [
"en"
]
},
"techniques": {
"frameworkAgreement": {
"buyerCategories": "NHS Shared Business Services act in an Agency capacity for and on behalf of its customers (Approved Organisations) - existing and new. These comprise of NHS and Social Care organisations (whether acting individually, or on behalf of, or together as members of any consortia) along with any other public or private sector bodies which NHS SBS authorises to use the resulting Framework.\nNHS Shared Business Services Limited (NHS SBS) intends to put in place a Framework Agreement for the provision of Interpretation \u0026 Translation Services for Healthcare to be used by NHS SBS Approved Organisations.\nOur Approved Organisation list can be found on:\nhttps://www.sbs.nhs.uk/services/framework-agreements-categories/",
"buyerLocationRestrictions": [
{
"gazetteer": {
"identifiers": [
"UK"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"GG"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"IM"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"JE"
],
"scheme": "GB-ITL"
}
}
],
"description": "There are two procurement routes for an Approved Organisation that wishes to use this Framework. A competitive process between the Suppliers in the relevant Lot, which may be preceded by a capability assessment, or an award without a competitive process to particular Supplier(s)\nSchedule 7 of the Framework explains the rules for both a competitive selection process and an award without a competitive process. \nA competitive selection process is the default ordering procedure under this Framework.",
"isOpenFrameworkScheme": true,
"method": "withAndWithoutReopeningCompetition",
"openFrameworkSchemeEndDate": "2034-01-04T23:59:59Z",
"type": "open"
},
"hasFrameworkAgreement": true
},
"tenderPeriod": {
"endDate": "2025-05-12T12:00:00+01:00"
},
"title": "Radiopharmaceutical Products (SBS10516)",
"value": {
"amount": 150000000,
"amountGross": 180000000,
"currency": "GBP"
}
}
}